Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 397563, 13 pages
http://dx.doi.org/10.1155/2015/397563
Research Article

Synergistic Inhibitory Effects of Cetuximab and Cisplatin on Human Colon Cancer Cell Growth via Inhibition of the ERK-Dependent EGF Receptor Signaling Pathway

1College of Pharmacy and Medical Research Center, Chungbuk National University, Cheongju, Chungbuk 361-763, Republic of Korea
2Korea Health Industry Development Institute (KHIDI), Cheongju, Chungbuk 363-951, Republic of Korea
3Ministry of Food and Drug Safety (MFDS), Cheongju, Chungbuk 361-709, Republic of Korea

Received 17 March 2015; Revised 4 May 2015; Accepted 24 May 2015

Academic Editor: Milica Pešić

Copyright © 2015 Dong Ju Son et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Dong Ju Son, Ji Eun Hong, Jung Ok Ban, et al., “Synergistic Inhibitory Effects of Cetuximab and Cisplatin on Human Colon Cancer Cell Growth via Inhibition of the ERK-Dependent EGF Receptor Signaling Pathway,” BioMed Research International, vol. 2015, Article ID 397563, 13 pages, 2015. https://doi.org/10.1155/2015/397563.